Therapeutics: Proteasome activator subunit 3 (PSME3)

Cancer

INDICATION: Colorectal cancer

Cell culture and mouse studies suggest combining inhibitors of PSME3 and

Read the full 133 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE